U.S. District Court Issues Decision Regarding CINVANTI® Patents
The U.S. District Court for the District of Delaware ruled that two key patents protecting Heron Therapeutics' lead product CINVANTI are invalid. The decision affects U.S. Patent Nos.
Key figures
- Patent numbers
- ["12,115,255","12,290,520"]
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.